In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 15th, 2005 | 28 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.61 | -0.24 | -12.36 | 2 | 4 | 0 | 70 | 386.532 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | EP0071460A1; EP0442744A2; EP0442744A3; EP0517918B1; EP0590272A2; EP0590272B1; EP0614662A1; EP0671924A1; EP0957891A1; US3687944; US4380624; US5252630; US5314932; US5656434; US5770376; US5854204; US5874423; US5985242; US6017949; US6037326; US6096543; WO1994 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Z81020-1-O | HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other | Other | 640 | 0.31 | Binding ≤ 10μM |
Z81247-1-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 1), Other | Other | 730 | 0.31 | Binding ≤ 10μM |
Z81247-1-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other | Other | 28 | 0.38 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 730 | 0.31 | Binding ≤ 1μM |
Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 640 | 0.31 | Binding ≤ 1μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 730 | 0.31 | Binding ≤ 10μM |
Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 640 | 0.31 | Binding ≤ 10μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 28 | 0.38 | Functional ≤ 10μM |